Answers are grounded in this paper and cite their sources.
Analysis shows differences in gut microbiota in myeloma patients based on antibiotic use, implying potential effects on CAR-T therapy outcomes.
Supplementary Figure S5 examines the potential impact of antibiotic use on gut microbiota composition in multiple myeloma patients, using PCA plots to compare the intestinal microbiota of patients who did and did not receive antibiotics at both apheresis and lymphodepletion.
No takes yet. Share an insight, caveat, or question.
Uribe‐Herranz et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: